retatrutide phase 2 Original Article: Triple–Hormone-Receptor Agonist for Obesity — A Trial https://t.co/jNL1GNnHPT #ADA23 retatrutide weight loss phase 2

PlexusDx believes precision wellness means understanding your unique genetic predispositions in peptide pathways alongside clinical biomarkers, enabling you and your provider to evaluate whether GLP-1 therapy may be a supportive option for your specific situation

Can I use an IUD or hormonal implant with GLP-1 therapy

If we had a treatment for obesity, they wouldn't have had that' (Hickey)

Additionally, shifts in healthcare policy regarding obesity treatment could expand insurance coverage, making these innovative pills available to a much wider audience

In contrast, GLP-1 agonists mimic a naturally occurring hormone, influencing blood sugar regulation and slowing down digestion, leading to reduced appetite and weight loss

These are the first Phase 3 data reported for retatrutide